Body Con Plus capsules pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested a product labelled Body Con Plus capsules and found that:
- the capsules contain the undeclared substances sibutramine and phenolphthalein.
- consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events.
- phenolphthalein is a prescription-only substance previously marketed as an oral laxative, withdrawn from sale from many markets in the late 1990’s due to concerns over its carcinogenicity with long term use.
The supply of Body Con Plus capsules containing undisclosed sibutramine and phenolphthalein is illegal.
Body Con Plus capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia may have bought the product online.
Licensed from the Commonwealth of Australia under a Creative Commons Licence.
The Commonwealth of Australia does not necessarily endorse the content of this publication.